Evidence Synthesis
Insecticide Sees Quarterly Boost in Gross Margin and Marginal Operating Leverage, Despite Declining Revenue Growth.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 17 Sept 2026, 01:19
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Insecticide Sees Quarterly Boost in Gross Margin and Marginal Operating Leverage, Despite Declining Revenue Growth.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 31.98 % | 9.47 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 9.47 % | 6.05 | ▲ |
| REVENUE_GROWTH_YOY | -11.5 % | -24.5 | ▲ |
| PRICE_CHANGE_PERCENT | 0.067 % | — | - |
| DAILY_VOLUME | 15,018 shares | 28,892 | ▼ |
| CLOSE_PRICE | 595.2 INR | 594.8 | ▲ |